Please assess the completion status of the following clinical trial:

Trial Title: Healthy Lifestyles for Mentally Ill People Who Have Experienced Weight Gain From Their Antipsychotic Medications - 2

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Must be a Veteran~* Diagnosis of psychotic disorders, schizophrenia, schizoaffective disorder and bipolar illness~* Age 18-70~* Clinically determined to require ongoing treatment with Second Generation Antipsychotics (SGA) such as olanzapine, risperidone, quetiapine, ziprasidone, aripiprazole, clozapine~* Experienced weight gain since treatment with SGA's~* Inpatient or outpatient at Long Beach, West Los Angeles, Sepulveda, or Downtown VA~* Competent to sign informed consent~Exclusion Criteria:~* Have recently been diagnosed with schizophrenia (less than 1 year)~* Are pregnant or breast feeding a baby~* Have a medically unstable condition

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Usual Care (Type: NO_INTERVENTION): Control group with time-matched study visits
- Lifestyle Balance (Type: ACTIVE_COMPARATOR): Weight management group education and individual counseling
- Usual Care then Lifestyle Balance (Type: OTHER): Participants originally randomized to Usual Care, allowed to change over to Lifestyle Balance at month 6 per their request.

Based on this trial design, predict the completion outcome and termination type (if applicable).